COPRELOTAMAB
UNII XQ7509L801

Substance Identification & Data

This profile provides standardized clinical and technical data for Coprelotamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XQ7509L801.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2348469-84-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
XQ7509L801
CAS Registry Number
2348469-84-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
COPRELOTAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C177097
National Cancer Institute reference terminology for clinical and research data.
INN ID
11435
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Coprelotamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

COPRELOTAMAB

Common Names & Synonyms

COPRELOTAMAB [INN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN TYROSINE KINASE RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL GB221 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GB221 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINE PROTEIN KINASE ERBB-2, EGFR2, HER2, HER-2, P185CERBB2, NEU, CD340)), HUMANIZED MONOCLONAL ANTIBODY

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus